News from Novo

Novo Nordisk sells hit weight-loss drug in China—at fraction of US price

Popular weight-loss drug Wegovy goes on sale in China

Here's why you should buy Viking Therapeutics instead of Eli Lilly

US minority veterans face unequal access to Ozempic and Wegovy, study finds

Novo Nordisk lifts curbs on Wegovy prescriptions in the U.S., says CEO

Novo Nordisk quarterly profit meets expectations as Wegovy maker narrows full-year guidance

Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

Madrigal stock soars after Novo Nordisk publishes promising results for weight-loss drug

Diabetes patients worry about insulin shortages as Ozempic use skyrockets

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds

Consumer groups ask FTC to block Novo Holdings-Catalent deal

US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal

Prediction: These 2 Stocks Will Join Nvidia, Meta, Apple, Amazon, and Microsoft in the Trillion-Dollar Club by 2030

Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound, caught up in East Coast trade shutdown

Evotec and Novo Nordisk in technology development partnership

Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

Novo Nordisk's market value of $570 billion is more than Denmark's annual GDP